Acute Appendicitis After COVID-19 Vaccines in Italy: A Self-Controlled Case Series Study.
Saved in:
| Title: | Acute Appendicitis After COVID-19 Vaccines in Italy: A Self-Controlled Case Series Study. |
|---|---|
| Authors: | Morciano C; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Massari M; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Cutillo M; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Belleudi V; Department of Epidemiology ASL Roma 1, Lazio Regional Health Service, Rome, Italy., Trifirò G; Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Mores N; Institute of Pharmacology, Pharmacovigilance, Policlinico Universitario A. Gemelli, Catholic University of Sacred Heart, Rome, Italy., Sapigni E; Hospital Assistance Service, General Directorate for Personal Care, Health and Welfare, Emilia-Romagna Region, Bologna, Italy., Puccini A; Hospital Assistance Service, General Directorate for Personal Care, Health and Welfare, Emilia-Romagna Region, Bologna, Italy., Zanoni G; Immunology Unit, University Hospital, Verona, Italy., Zorzi M; Cancer Registry of Veneto, Azienda Zero, Padua, Italy., Monaco G; Department of Health of Lombardy Region, Epidemiology Observatory, Milan, Italy., Leoni O; Department of Health of Lombardy Region, Epidemiology Observatory, Milan, Italy., Del Zotto S; Regional Health Authority, Friuli Venezia Giulia Region, Udine, Italy., Samez S; Regional Pharmacovigilance Centre, Trieste, Italy., Mayer F; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Marano G; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Menniti Ippolito F; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Da Cas R; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Traversa G; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Spila Alegiani S; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy. stefania.spila@iss.it. |
| Source: | Drug safety [Drug Saf] 2024 Nov; Vol. 47 (11), pp. 1157-1169. Date of Electronic Publication: 2024 Jul 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39068268 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Acute Appendicitis After COVID-19 Vaccines in Italy: A Self-Controlled Case Series Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Morciano+C%22">Morciano C</searchLink>; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Massari+M%22">Massari M</searchLink>; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Cutillo+M%22">Cutillo M</searchLink>; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Belleudi+V%22">Belleudi V</searchLink>; Department of Epidemiology ASL Roma 1, Lazio Regional Health Service, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Trifirò+G%22">Trifirò G</searchLink>; Department of Diagnostics and Public Health, University of Verona, Verona, Italy.<br /><searchLink fieldCode="AU" term="%22Mores+N%22">Mores N</searchLink>; Institute of Pharmacology, Pharmacovigilance, Policlinico Universitario A. Gemelli, Catholic University of Sacred Heart, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Sapigni+E%22">Sapigni E</searchLink>; Hospital Assistance Service, General Directorate for Personal Care, Health and Welfare, Emilia-Romagna Region, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Puccini+A%22">Puccini A</searchLink>; Hospital Assistance Service, General Directorate for Personal Care, Health and Welfare, Emilia-Romagna Region, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Zanoni+G%22">Zanoni G</searchLink>; Immunology Unit, University Hospital, Verona, Italy.<br /><searchLink fieldCode="AU" term="%22Zorzi+M%22">Zorzi M</searchLink>; Cancer Registry of Veneto, Azienda Zero, Padua, Italy.<br /><searchLink fieldCode="AU" term="%22Monaco+G%22">Monaco G</searchLink>; Department of Health of Lombardy Region, Epidemiology Observatory, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Leoni+O%22">Leoni O</searchLink>; Department of Health of Lombardy Region, Epidemiology Observatory, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Del+Zotto+S%22">Del Zotto S</searchLink>; Regional Health Authority, Friuli Venezia Giulia Region, Udine, Italy.<br /><searchLink fieldCode="AU" term="%22Samez+S%22">Samez S</searchLink>; Regional Pharmacovigilance Centre, Trieste, Italy.<br /><searchLink fieldCode="AU" term="%22Mayer+F%22">Mayer F</searchLink>; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Marano+G%22">Marano G</searchLink>; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Menniti+Ippolito+F%22">Menniti Ippolito F</searchLink>; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Da+Cas+R%22">Da Cas R</searchLink>; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Traversa+G%22">Traversa G</searchLink>; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Spila+Alegiani+S%22">Spila Alegiani S</searchLink>; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy. stefania.spila@iss.it. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229002928%22">Drug safety</searchLink> [Drug Saf] 2024 Nov; Vol. 47 (11), pp. 1157-1169. <i>Date of Electronic Publication: </i>2024 Jul 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9002928 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1942 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201145916%22">01145916 </searchLink><i>NLM ISO Abbreviation: </i>Drug Saf <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39068268 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40264-024-01462-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1157 Titles: – TitleFull: Acute Appendicitis After COVID-19 Vaccines in Italy: A Self-Controlled Case Series Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Morciano C – PersonEntity: Name: NameFull: Massari M – PersonEntity: Name: NameFull: Cutillo M – PersonEntity: Name: NameFull: Belleudi V – PersonEntity: Name: NameFull: Trifirò G – PersonEntity: Name: NameFull: Mores N – PersonEntity: Name: NameFull: Sapigni E – PersonEntity: Name: NameFull: Puccini A – PersonEntity: Name: NameFull: Zanoni G – PersonEntity: Name: NameFull: Zorzi M – PersonEntity: Name: NameFull: Monaco G – PersonEntity: Name: NameFull: Leoni O – PersonEntity: Name: NameFull: Del Zotto S – PersonEntity: Name: NameFull: Samez S – PersonEntity: Name: NameFull: Mayer F – PersonEntity: Name: NameFull: Marano G – PersonEntity: Name: NameFull: Menniti Ippolito F – PersonEntity: Name: NameFull: Da Cas R – PersonEntity: Name: NameFull: Traversa G – PersonEntity: Name: NameFull: Spila Alegiani S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2024 Nov Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1179-1942 Numbering: – Type: volume Value: 47 – Type: issue Value: 11 Titles: – TitleFull: Drug safety Type: main |
| ResultId | 1 |